e-learning
resources
Stockholm 2002
Wednesday 18.09.2002
Interstitial lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
A. Capelli, A. Di Stefano, M. Lusuardi, I. Gnemmi, C. F. Donner (Veruno, Italy)
Source:
Annual Congress 2002 - Interstitial lung disease
Session:
Interstitial lung disease
Session type:
Assembly Symposium
Number:
3751
Disease area:
Interstitial lung diseases
Abstract
We have observed a downregulation of CCR5 expression in alveolar cells and an important role played by CC-chemokines (MIP 1alfa and MIP-1beta) in fibrotic stages of sarcoidosis (1). To evaluate if there is a similar involvement in IPF, 35 subjects were studied. Eighteen non smoker control subjects and 17 patients affected by IPF underwent BAL. CCR5 expression was evaluated in alveolar macrophages and lymphocytes; MIP-1alfa, MIP-1beta and MCP-1 levels were measured with ELISA in BAL fluid concentrated 10 fold. The table shows the results as median and range:
MIP-1α pg/ml
MIP-1β pg/ml
MCP-1 pg/ml
Controls NS
1.2 (0.0 - 3.8)
3.4 (0.3 - 6.8)
4.6 (0.5 - 119.4)
IPF
1.6 (1.0 - 11.1)*
6.2 (1.3 - 96.0)**
60.1 (16.7 - 251.3)***
p = 0.036 , ** p = 0.0015, *** p < 0.0001 vs controls.
A significant decrease of CCR5 expression was observed in lymphocytes (5.0% vs 20.5% p < 0.002) but not in macrophages ( 2.3% vs 2.5% p = NS) in IPF compared with controls. In IPF as in sarcoidosis, CC-chemokines are involved in the inflammatory reaction of the lung. The CCR5 expression, decreased in lymphocytes, is in agreement with previous observations of a Th2 immunity reaction in this interstitial lung disease.
1) Capelli A. et al. Am J Respir Crit Care Med 2002;165:236-241.
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Capelli, A. Di Stefano, M. Lusuardi, I. Gnemmi, C. F. Donner (Veruno, Italy). CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF). Eur Respir J 2002; 20: Suppl. 38, 3751
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003
Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007
The expression of the chemokine receptors CXCCR3 and CCR4 on T cells reflects the Th2 switch in the bronchoalveolar lavage (BAL) of idiopathic pulmonary fibrosis (IPF) patients
Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases
Year: 2004
Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
A comparison of T lymphocytes (TLs) subpopulations in lung tissue and in bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2004; 24: Suppl. 48, 43s
Year: 2004
Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005
CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 25: 701-707
Year: 2005
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis-usual interstitial pneumonia (IPF-UIP) using SELDI-mass spectrometry
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007
Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer.
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Toll-like receptor 4 is overexpressed in bronchoalveolar lavage fluid of patients with fibrotic idiopathic interstitial pneumonias (F-IIPs): preliminary results
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP)
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004
Increased Clara cell protein 16 levels in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001
Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept